Stock listing
A1W0MW Stock Price, News, Filings & Events — Ptc Therapeutics, Inc.
Selected listing: A1W0MW · LSX · EUR · DE
This page tracks Ptc Therapeutics, Inc.'s A1W0MW:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1W0MW:LSX. A1W0MW:LSX is the stock-level entry point for investors researching Ptc Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A1W0MW:LSX
- Asset type
- Stock
- Market cap
- $5.83B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Ptc Therapeutics, Inc. A1W0MW:LSX stock context
This page tracks Ptc Therapeutics, Inc.'s A1W0MW:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1W0MW:LSX. A1W0MW:LSX is the stock-level entry point for investors researching Ptc Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Ptc Therapeutics, Inc.
PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and...
August 24, 2026
PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program
August 12, 2026
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
July 30, 2026
PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026
July 16, 2026
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes
June 15, 2026
Ptc Therapeutics, Inc. earnings calls
PTC Therapeutics, Inc. (PTCT) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
PTC Therapeutics, Inc. (PTCT) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
PTC Therapeutics, Inc. (PTCT) Q4 2025 Earnings Call
February 19, 2026 · Replay with transcript and chapters
PTC Therapeutics, Inc. (PTCT) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
PTC Therapeutics, Inc. (PTCT) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
PTC Therapeutics, Inc. (PTCT) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Research Ptc Therapeutics, Inc.
Ptc Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A1W0MW:LSX.
Ptc Therapeutics, Inc. company profile
View the public company page for Ptc Therapeutics, Inc. on 6ix.
Ptc Therapeutics, Inc. news
Read company news and market updates connected to Ptc Therapeutics, Inc..
Ptc Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Ptc Therapeutics, Inc..
Alternate listings
PTCT:NASDAQ
US · USD
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is A1W0MW:LSX.
BH3:GETTEX
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is A1W0MW:LSX.
A1W0MW:LS
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is A1W0MW:LSX.
PTCT:BOATS
US · USD
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is A1W0MW:LSX.
P91:BX
CH · CHF
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is A1W0MW:LSX.
BH3:DUS
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is A1W0MW:LSX.
BH3:FWB
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is A1W0MW:LSX.
BH3:HAM
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is A1W0MW:LSX.
BH3:MUN
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is A1W0MW:LSX.
BH3:SWB
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is A1W0MW:LSX.
BH3:TRADEGATE
DE · EUR
Alternate listing for Ptc Therapeutics, Inc.; the primary context on this page is A1W0MW:LSX.